Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.

NCT06485232 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Neuromyelitis Optica Spectrum Disorders
Myasthenia Gravis, Generalized
Multiple Sclerosis
Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Interventions

DRUG: Universal BCMA CAR-T
DRUG: Universal CD19 CAR-T
DRUG: Universal BCMA CAR-T; Universal CD19 CAR-T

Sponsor

Xuanwu Hospital, Beijing

Collaborators

[object Object]